Novartis AG
SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES
Last updated:
Abstract:
The present invention relates to silent Fc variants of anti-CD40 antibodies and compositions and methods of use of said antibodies for treating pathological disorders such as autoimmune and inflammatory disorders and/or for preventing or reducing the risk of graft rejection in transplantation.
Status:
Application
Type:
Utility
Filling date:
16 Aug 2021
Issue date:
30 Jun 2022